Maximizing Value of Intellectual Property Portfolios in Cell and Gene Therapies to Attract Investors
11 Feb 2026
Theatre 2
Roundtable
- Advantages and strategies for extending Loss of Exclusivity (LOE) beyond regulatory exclusivity
- Preparing for investor IP diligence scrutiny
- Knowing the patent landscape to proactively address freedom-to-operate inquiries
